Boundless Bio Inc. Common...
(BOLD)
undefined
undefined%
At close: undefined
2.62
0.38%
After-hours Jan 07, 2025, 04:10 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY18 | FY17 | FY16 |
| Net Income | -49.43M | -45.90M | -25.21M | -128.82M | -90.24M | -59.67M |
| Depreciation & Amortization | 957.00K | 942.00K | 682.00K | 7.46M | 3.75M | 1.58M |
| Stock-Based Compensation | 3.34M | 2.29M | 1.16M | n/a | 6.88M | 2.00M |
| Other Working Capital | -2.46M | -1.04M | -2.06M | 272.54M | 22.73M | 671.00K |
| Other Non-Cash Items | 2.38M | 1.70M | 423.00K | -279.73M | -30.57M | 7.07M |
| Deferred Income Tax | -3.30M | 503.00K | 536.00K | n/a | 2.25M | -95.21M |
| Change in Working Capital | -799.00K | 866.00K | -837.00K | 276.62M | 23.42M | 95.21M |
| Operating Cash Flow | -46.85M | -39.60M | -23.25M | -107.98M | -84.51M | -49.02M |
| Capital Expenditures | -633.00K | -1.07M | -2.03M | -11.61M | -7.55M | -16.65M |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -160.12M | -42.60M | -77.49M | -382.02M | -152.71M | -104.04M |
| Sales Maturities Of Investments | 122.50M | 59.80M | 20.24M | 208.59M | 126.83M | 58.62M |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 16.00K |
| Investing Cash Flow | -38.26M | 16.13M | -59.28M | -185.05M | -33.44M | -62.05M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -144.35M | -38.97M | -36.36M |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 97.90M | 126.00K | 105.53M | 398.46M | 120.55M | 75.36M |
| Financial Cash Flow | 97.90M | 126.00K | 105.53M | 398.46M | 120.55M | 75.36M |
| Net Cash Flow | 12.78M | -23.34M | 22.99M | 105.44M | 2.61M | -35.70M |
| Free Cash Flow | -47.49M | -40.66M | -25.28M | -119.59M | -92.06M | -65.67M |